Olmesartan Recall: How to Check Whether Your Blood Pressure Medication Is Affected

If you take olmesartan, do not assume that every bottle has been recalled. U.S. recalls identify particular manufacturers, combinations of active ingredients, strengths, package sizes, and manufacturing lots. The safest first step is to compare your prescription with the exact details in the U.S. Food and Drug Administration (FDA) Enforcement Reports, then ask your dispensing pharmacist to confirm whether your supply is affected. Do not stop or change a prescribed blood-pressure medication on your own.

Information checked November 3, 2026, for the United States. Recall listings can change, and the examples below are not an exhaustive list of all historical or newly announced actions. The FDA's live record and instructions from the recalling company take precedence over a static article.

Which olmesartan products are involved in recent U.S. recalls?

Olmesartan medoxomil belongs to a group of blood-pressure drugs called angiotensin II receptor blockers (ARBs). It may be prescribed alone or combined with other medications, including amlodipine, a calcium channel blocker, and hydrochlorothiazide, a diuretic. A recall of one combination product does not establish that an olmesartan-only tablet or a different manufacturer's product is affected.

Recent 2026 U.S. FDA enforcement reporting identifies these specific olmesartan-containing combination products. The lot and National Drug Code (NDC) identifiers are more useful for checking your supply than a headline saying only “olmesartan recall.”

For the Macleods products, Taiwan's official Food and Drug Administration also published a November 2, 2026, safety notice citing the U.S. action and the two affected lots. That notice concerns Taiwan's import status; it does not replace a U.S. patient's need to check FDA records and their pharmacy. The Ascend example is identified in U.S. enforcement reporting as recall D-0045-2027; the Macleods lots can be found by searching the company, medication, and lot identifiers. Search the relevant record in the FDA database if its page or status has changed.

The problem described as failed dissolution specifications means tablets did not meet a laboratory standard for how they dissolve. This raises a quality and performance concern; it does not, by itself, prove that every tablet failed to work or that every patient experienced harm. These examples are different from recalls involving nitrosamine impurities, and their stated reasons should not be mixed together.

What information should you have before checking your bottle?

Gather the prescription container, any original carton or blister packaging, your pharmacy's name, and the date you received the medication. Look for:

• Full drug name: Check all ingredients, not merely the word “olmesartan.”
• Strength: Combination products have separate milligram amounts for each ingredient.
• Manufacturer, labeler, or distributor: The company on the pharmacy label may differ from the company that made the tablets.
• NDC: The National Drug Code is a three-segment identifier used to identify listed drug products and packaging. It helps narrow the product but is not a substitute for a lot number.
• Lot or batch number and expiration date: These identify the particular manufacturing supply addressed by a recall.

An orange pharmacy dispensing vial may not show the manufacturer's original lot number. That is common and does not mean your medication is safe or recalled. Ask the dispensing pharmacist to trace the product using the pharmacy's inventory, dispensing records, or original stock bottle. If you use a mail-order pharmacy or pills have been transferred to a weekly organizer, request the same verification from the provider that filled the prescription.

How to check an olmesartan recall step by step

Step 1: Open an official FDA recall source

Start with the FDA Enforcement Reports. Search for the full drug name, the recalling firm, the NDC, or a recall number. Review the product description, code information, recall reason, classification, initiation date, and status. The FDA also maintains a separate drug recall announcements page, but not every recall has a standalone press release.

Step 2: Match the full product details, not just one word

Suppose a notice lists the Macleods 40 mg/10 mg/12.5 mg three-drug tablet, NDC 33342-246-07, lot 12251163A. A bottle labeled simply “olmesartan medoxomil 20 mg” is not automatically included in that specific recall, even though both medicines contain olmesartan. Conversely, a bottle without a visible lot number cannot be cleared just because the lot is missing from the pharmacy label.

Step 3: Confirm the lot with your pharmacist

Call the pharmacy that dispensed the prescription. Ask: “Can you verify the manufacturer, NDC, and lot number of the olmesartan-containing tablets I received, and whether my fill is part of the current FDA recall?” Give the dispensing date and prescription number if requested. Do not post photos containing your name, address, or prescription number on public social media.

Step 4: Make a medication plan before changing a dose

If your lot is affected—or the pharmacy cannot establish that it is unaffected—contact your pharmacist or prescribing clinician promptly. They can explain the recall's specific instructions, whether an unaffected lot of the same medicine is available, and whether a new prescription or alternative treatment is needed. Ask whether your blood pressure should be checked more frequently during the transition. Do not split tablets, skip doses, double doses, or substitute another person's medication to manage the recall yourself.

Step 5: Follow the return or disposal directions

Keep the bottle and packaging available until your pharmacy tells you how to handle the affected tablets, including any return or replacement process. Do not flush medication or throw it away before checking the applicable recall instructions. If disposal is required, the FDA's drug disposal guidance recommends an appropriate drug take-back option for most medicines.

What does an FDA Class II recall mean?

The FDA uses Class II for situations in which exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote. It is a regulatory risk classification, not a declaration that every patient taking that medicine has been injured. The agency may classify a recall after the company has already begun notifying its customers; the recall initiation date, classification date, and weekly report date can therefore differ.

A notice may also specify the depth of recall—for example, wholesalers, retail pharmacies, or consumers. A pharmacy-level recall notice does not always require each patient to send back a bottle. Follow the actual recall instructions and speak with your pharmacist rather than interpreting the class number as an instruction to stop treatment. The FDA explains these distinctions in Understanding Drug Recalls and its Enforcement Report definitions.

When should you seek medical help?

Do not wait for recall paperwork if you have urgent symptoms. Call 911 for chest pain, serious trouble breathing, new weakness, difficulty speaking, or other signs of an emergency. The American Heart Association specifically advises calling 911 when blood pressure is higher than 180/120 mm Hg and accompanied by symptoms such as chest pain, shortness of breath, weakness, vision changes, or trouble speaking. If a reading is higher than 180/120 but you have no such symptoms, repeat the measurement after at least one minute and contact a health professional promptly if it remains that high. See the American Heart Association's emergency guidance.

Even if you feel well, continue following your clinician's blood-pressure monitoring plan. Olmesartan controls blood pressure but does not cure hypertension; the National Library of Medicine's olmesartan information advises against stopping it without talking with a doctor. Suspected adverse reactions, therapeutic failure, or product quality problems can be reported to the FDA MedWatch program. Reporting is not a substitute for medical care.

Common mistakes to avoid when reading recall news

• Assuming the ingredient name is enough: “Olmesartan” can refer to single-drug products and several different combination tablets.
• Ignoring the lot: An NDC can identify a product and package while several different manufacturing lots share that NDC.
• Confusing product counts with patients: A notice describing thousands of bottles does not establish how many people took those pills.
• Taking the lack of a press release as proof of no recall: The FDA Enforcement Reports can include actions that were announced through letters to distributors or pharmacies.
• Assuming an old article is current: Product status, affected codes, and recall instructions can be updated after a headline is published.
• Interrupting blood-pressure treatment without a plan: Work with a pharmacist or clinician to prevent an avoidable gap in therapy.

Quick questions

Are all olmesartan tablets recalled?

No. The 2026 examples above identify specific combination medicines, manufacturers, packages, and lots. They do not establish a blanket recall of all olmesartan products sold in the United States.

What if my bottle has no NDC or lot number?

Ask the pharmacy that filled it. Provide the pharmacy label information and dispensing date so staff can check their original packaging and records.

Should I stop taking my tablets while I check?

Do not stop or change prescribed blood-pressure treatment without advice from a clinician or pharmacist, unless you are given specific urgent instructions by a qualified health professional or the applicable recall notice. Contact the pharmacy promptly if you suspect an affected lot.

How do I know whether a recall is still active?

Look up the recall number or product in the FDA Enforcement Reports and read its current status and any updated code information. A historical FDA listing may remain searchable after the recall is terminated, so always consider its dates and status.

Bottom line: The useful question is not simply “Was olmesartan recalled?” but “Does my exact product, strength, NDC, and lot match an official notice?” Confirm those details with your pharmacist and arrange any necessary replacement without creating a gap in blood-pressure treatment.